Seminars in Arthroplasty
Volume 21, Issue 2 , Pages 85-86, June 2010

Deep Vein Thrombosis Prophylaxis: Better Living Through Chemistry—Opposes

  • Clifford W. Colwell Jr, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Clifford W. Colwell Jr, MD, Center for Orthopaedic Research and Education at Scripps Clinic, 11025 North Torrey Pines Rd., Suite 140, La Jolla, CA 92037

Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, CA, USA

The risk for venous thromboembolic events after total joint arthroplasty is well known. Use of pharmacologic prophylaxis is recommended by many guidelines, but with pharmacologic prophylaxis comes the possibility of bleeding with a major surgical incision. With a new mobile compression device that can be worn in or out of bed, in the hospital, or at home, or a rehabilitation facility, the concern for major bleeding is eliminated, and the rate of venous thromboembolic events is similar to that of pharmacologic prophylaxis.

Keywords: deep vein thrombosis, total joint arthroplasty, bleeding, portable compression device, prophylaxis, compliance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1045-4527(09)00086-8

doi:10.1053/j.sart.2009.12.003

Seminars in Arthroplasty
Volume 21, Issue 2 , Pages 85-86, June 2010